Join our distributor network

Join our distributor network

As a reference for healthcare professionals since 2005 in France in the field of rheumatology LABRHA is now ready to develop its activity across the globe and become a major actor internationally. In order to achieve this challenge, we are looking to expand our distributor network to provide practitioners and...
About LABRHA

About LABRHA

Founded by Patrick Sac-Epée in 2005 in the city of Lyon in France, LABRHA is dedicated to the conception and development of natural products in rheumatology. OUR MISSION LABRHA’s mission is to meet patients’ and practitioners’ needs helping them to find, in the management of rheumatic diseases and musculoskeletal pains,...
New intra-articular injections combining HA + Mannitol

New intra-articular injections combining HA + Mannitol

LABRHA offers today a complete range of new and innovative viscosupplements, each one having its own characteristics and specific indications. With LABRHA’s viscoelastic solutions, you can treat all type of joints (including small and medium-sized joints) and adapt treatment depending on the severity of the disease (from grade I to...
Focus on quality and efficacy with strong work on basic and clinical research

Focus on quality and efficacy with strong work on basic and clinical research

Experimental studies and clinical trials are endlessly conducted on our products. All experimental studies and clinical trials to date have shown significant results. Several of them have been published in international peer-reviewed scientific journals. LABRHA also displays each year several scientific posters at different congresses Viscosupplements: HAPPYVISC (ongoing) Randomized, prospective,...
Cope with Fibromyalgia thanks to LABRHA's natural products for fibromyalgia sufferers

Cope with Fibromyalgia thanks to LABRHA’s natural products for fibromyalgia sufferers

LESS PAIN AND FATIGUE AND MORE ENERGY: COPE WITH FIBROMYALGIA THANKS TO FIBROMYALGINE® & FIBROMYALGINE® FORTE! Fibromyalgia is one of the most common chronic pain condition. It affects an estimated 2% of world population. Fibromyalgia is about seven times more common in women than men, and is more likely to...
AINAT®: First natural anti-inflammatory product

AINAT®: First natural anti-inflammatory product

Risk of adverse effects of classic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): AINAT®: Natural and well tolerated solution with anti-inflammatory action Thanks to its exclusive formulation combining 3 traditional medicinal plants with anti-inflammatory properties acting in total synergy , Ainat™ helps reduce muscle and joint discomfort and improves mobility and quality of...
NUTROS®: Discover the first intelligent Calcium/Vitamin D to promote bone health

NUTROS®: Discover the first intelligent Calcium/Vitamin D to promote bone health

Calcium bioavailability: inulin content of Nutros® makes the difference! Beyond adequate Calcium intake, Calcium bioavailability is also an important parameter to keep bones strong and healthy. Calcium is the most common and abundant mineral in the human body. It is a structural component of bones, teeth, and soft tissues and...
Look after your joints and improve your quality of life with LABRHA's natural products for joint health

Look after your joints and improve your quality of life with LABRHA’s natural products for joint health

Understanding joints A joint is where two bones meet. Joints hold the bones together and allow our rigid skeleton to move and be flexible. Cartilage is a hard, smooth tissue that covers the end of bones. Between the cartilage of two bones which form a joint, there is a small...
Keep your body on move: Discover LABRHA's range of products for tendon health

Keep your body on move: Discover LABRHA’s range of products for tendon health

EVERY MOVE YOU MAKE IS DEPENDENT ON YOUR TENDONS Tendons are strong connective tissues that connect muscles to bones and allow movement. Every move you make is then dependent on your tendons, on their health and strength. However, tendons are regularly prone to injuries resulting in pain, inflammation and weakening...
Latest entries
Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to assess in daily practice conditions,...
LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED HYALURONIC ACID (HAppyMini®) IN TRAPEZIOMETACARPIAL...
Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Bard, D. Baron, P. Richette, T. Conrozier. Cartilage. February-01-2017. Doi: 10.1177/1947603517693043 The paper « Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering...
Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. The study « Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis », published in Journal of Orthopaedic Research this month, has been designed to identify clinical and radiological factors associated with lack of...
Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62  (36-87) BMI 25,4 (17,9-41,8) 1 injection of HANOX-M-XL(HAppyCross®) under...